ELIZABETH RAMSEY: Open Payments
NPI 1710290010 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,845 in 169 payments from 17 companies in 2025. Trend: 2023 $2,082 · 2024 $2,301 · 2025 $2,845
Food & beverage: $2,662Education: $183
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 64 | $986 |
| Alkermes, Inc. | 18 | $310 |
| Neurocrine BioSciences, Inc. | 11 | $258 |
| E.R. Squibb & Sons, L.L.C. | 16 | $220 |
| Axsome Therapeutics, Inc. | 17 | $219 |
| Vanda Pharmaceuticals Inc. | 9 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $119 |
| Lundbeck LLC | 5 | $96 |
| ABBVIE INC. | 5 | $96 |
| Otsuka America Pharmaceutical, Inc. | 5 | $88 |
Products named: UZEDY, AUSTEDO XR, ARISTADA, INGREZZA, Auvelity, COBENFY, REXULTI, FANAPT.
Industry payments across PA — which companies pay providers there.
